其他几家正在考虑提出报价的私募股权投资公司均已退出。早在9月，知情人士表示，包括黑石集团、Advent International、TPG Capital、CVC Capital和Hellman & Friedman在内的私募股权公司正在评估对博士伦可能提出的收购要约。The acquisition quote for Bausch Health is expected to be between 13 billion US dollars and 14 billion US dollars, or $25 per share. The formal acquisition quote is expected to be announced by the end of this month.
According to sources familiar with the matter, a private equity company$TPG Inc (TPG.US)$And.$Blackstone (BX.US)$is jointly bidding$Bausch + Lomb Corp. (BLCO.US)$As of the time of publication, the stock has risen by 7.09% during the trading session, quoting $20.85.
The expected acquisition quote for Bausch Lomb is 13 to 14 billion US dollars, or $25 per share. The formal acquisition quote is expected to be announced by the end of this month.
Other private equity firms considering submitting quotes have all withdrawn. As early as September, sources familiar with the matter said that private equity firms including Blackstone Group, Advent International, TPG Capital, CVC Capital, and Hellman & Friedman were evaluating a potential acquisition offer for Bausch Health.
This eye health company is considering a sale to address$Apollo Global Management (APO.US)$The concerns raised by company lenders and other financial institutions over its plans with the parent company$Bausch Health (BHC.US)$Concerns have been raised in relation to the separation proposal due to its impact on the parent company's balance sheet. Apollo Global Management has expressed concerns over the divestiture plan.
Editor/ping
